Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes

Immunology and Microbiology

• Regulatory T Cell 100%
• Dendritic Cell 100%
• Memory T Cell 100%
• Cytokine 100%
• T Cell 100%
• Insulin 100%
• B Cell 50%
• Regulatory B Cells 50%
• Interleukin 6 50%
• Immunocompetent Cell 50%
• Immunotherapy 50%
• Interleukin 10 50%
• Neutrophil 50%
• Cell Protection 50%
• Glycemic Control 50%
• Interleukin 2 50%

Keyphrases

• Partial Remission 100%
• Pediatric Diabetes 100%
• T Cells 50%
• Type 1 Diabetes Mellitus (T1DM) 33%
• Interleukin-17 (IL-17) 33%
• Type I Diabetes 33%
• Effector Memory 33%
• Dendritic Cells 33%
• Remission 33%
• Immunological Biomarkers 33%
• Memory T Lymphocytes 33%
• Immune Cells 16%
• Personalized Therapy 16%
• Pediatric Patients 16%
• Interleukin-10 16%
• Interleukin-6 16%
• Nave 16%
• Therapeutic Window 16%
• Predictive Models 16%
• Glycemic Control 16%
• Regulatory T Cells 16%
• Interleukin-2 16%
• Metabolic Factors 16%
• Working Diagnosis 16%
• Control Subjects 16%
• Therapeutic Management 16%
• Disease Prognosis 16%
• B Lymphocytes 16%
• Immunomodulatory 16%
• TGF-1 16%
• Monocytes 16%
• Type 1 Diabetes Onset 16%
• Neutrophils 16%
• Regulatory B Cells 16%
• Immunological Characterization 16%
• Index-based 16%
• Cell Protection 16%
• Insulin Requirement 16%
• Longitudinal Follow-up 16%
• Remitters 16%
• Total Daily Insulin Dose 16%
• Immunologic Factors 16%
• New-onset Type 1 Diabetes 16%
• Immunoregulatory Mechanisms 16%
• Potential Monitoring 16%

Neuroscience

• T Cell 100%
• B Cell 50%
• Cytokine 50%
• Interleukin 6 25%
• Interleukin 10 25%
• Interleukin 2 25%
• Immunotherapy 25%